Tucuvi

Tucuvi is a Digital Health startup based in Madrid, Spain that has raised $20M in venture capital across 2 funding rounds since 2019. The company reached Series A stage in August 2022 with a $0.8M round led by institutional investors. Tucuvi's investor base includes 6 institutional funds, with K Fund leading the most recent equity round.

Tucuvi is an AI Care Management platform that automates clinical workflows through voice AI. Its flagship product, LOLA, is a clinical voice agent that conducts autonomous phone conversations with patients for post-surgical follow-ups, chronic disease monitoring, and care coordination across 50+ clinical workflows. Tucuvi is the first platform to receive European regulatory approval as a Class IIb Software as a Medical Device for both its voice agent and patient management platform, having monitored over one million patients across 60+ healthcare organizations — including NHS trusts and major Spanish hospitals — and achieving automation rates of up to 80% in nursing follow-up tasks. Founded in 2019 in Madrid, the company raised a €17 million ($20 million) Series A in January 2026, co-led by K Fund and Cathay Innovation, and has offices in both Madrid and New York.